HIV-1 vs HIV-2
- Topic
HIV-2 causes the same disease as HIV-1 but more slowly, and tests and drugs made for HIV-1 can miss or fail it.
What it is
HIV-1 and HIV-2 are two related retroviruses that infect CD4 T cells and can cause AIDS. HIV-1 causes most infections worldwide; HIV-2 is concentrated in West Africa and in countries with ties to it. HIV-2 keeps a lower viral load, spreads less easily and progresses more slowly, but it needs its own viral load test and does not respond to several HIV-1 drugs.
Step by step
- Both viruses infect CD4 T cells and, untreated, can deplete them until opportunistic infections appear.
- HIV-2 keeps plasma viral load low or even undetectable in most patients, although it still hides in cells as proviral DNA.
- Less virus in blood and genital fluids means fewer infections passed to partners and babies.
- Less virus also means a slower CD4 fall, a longer symptom-free phase, and fewer people reaching AIDS.
- HIV-2 enzymes and envelope differ: the NNRTI pocket and the enfuvirtide target do not fit, and some protease inhibitors bind less well.
- So an HIV-1 viral load or an NNRTI regimen applied to HIV-2 gives false reassurance or treatment failure.
HIV-1 vs HIV-2: what changes
| Feature | HIV-1 | HIV-2 |
|---|---|---|
| Where it is found | Worldwide; most HIV infections | West Africa (highest in Guinea-Bissau, around 8% of adults); countries with ties to the region, such as Portugal and France |
| Transmission | Efficient sexual and mother-to-child transmission | Less efficient: sexual transmission 5–9 times and mother-to-child transmission 10–20 times lower than HIV-1 |
| Course without treatment | Most progress to AIDS | Lower viral load, slower CD4 fall, longer asymptomatic phase; only 15–25% progress to AIDS, but those who do get the same opportunistic infections |
| Diagnosis | Antigen/antibody screen, then HIV-1/HIV-2 differentiation immunoassay; HIV-1 RNA test if results disagree | Same screen; the differentiation immunoassay names HIV-2 (or leaves it undifferentiated); confirmation needs HIV-2-specific RNA testing |
| Viral load | Standard HIV-1 RNA tests | HIV-1 tests do not measure it; HIV-2 RNA assays, often specialised or in-house; frequently low or undetectable |
| Drug susceptibility | All main classes active | Naturally resistant to NNRTIs and enfuvirtide; reduced to some protease inhibitors (atazanavir, nelfinavir, tipranavir); darunavir, lopinavir and saquinavir active; integrase inhibitors and NRTIs active |
Clinical notes
- Think of HIV-2 in people from West Africa or with partners from there, and in Portugal- or France-linked patients.
- A person with a positive HIV screen, a low CD4 count and an 'undetectable' HIV-1 viral load without treatment may have HIV-2.
- Where differentiation tests are not available, HIV-2 can be treated by mistake with NNRTI-based regimens that do not work on it.
In the lab
- Step 1: antigen/antibody immunoassay that detects HIV-1 and HIV-2 antibodies and HIV-1 p24 antigen.
- Step 2: if reactive, an immunoassay that differentiates HIV-1 from HIV-2 antibodies.
- Step 3: if step 2 is negative or indeterminate, an HIV-1 nucleic acid test; HIV-2 or undifferentiated results go to HIV-2-specific testing.
- Follow-up: CD4 count plus an HIV-2 RNA viral load, not an HIV-1 assay.
Common traps
- An undetectable HIV-1 viral load in HIV-2 means good control: HIV-1 assays do not measure HIV-2; only an HIV-2 RNA test tells.
- HIV-2 is harmless: most people progress slowly, but without treatment some develop AIDS with the same opportunistic infections.
- Any first-line HIV regimen works for HIV-2: NNRTIs (efavirenz, nevirapine) and enfuvirtide never work, and some protease inhibitors are weaker; regimens use NRTIs with an integrase inhibitor or an active protease inhibitor such as darunavir.
- A reactive screen with a negative HIV-1 differentiation result is a false positive: it may be HIV-2 or very early HIV-1, so RNA testing comes next.
Test yourself
Think of the answer, then tap the question to see it.
A man from Guinea-Bissau has a reactive HIV screen, a CD4 count that has fallen over years and an undetectable HIV-1 viral load without treatment. What is the likely explanation and the next test?
HIV-2 infection: HIV-1 viral load tests do not measure HIV-2. The differentiation immunoassay and an HIV-2-specific RNA test are next.
Why is HIV-2 passed on less often, both sexually and from mother to child?
It keeps a much lower viral load in blood and genital fluids, so each exposure carries less virus.
Which antiretroviral classes do not work against HIV-2, and which are relied on instead?
NNRTIs and the fusion inhibitor enfuvirtide do not work, and some protease inhibitors are weaker; NRTIs with an integrase inhibitor (or an active protease inhibitor such as darunavir) are used.
Is HIV-2 a benign infection that never needs attention?
No. It progresses more slowly and only a minority reach AIDS, but untreated HIV-2 can still cause AIDS with the same opportunistic infections.
Connections
Microorganisms1
Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.
Sources: Human Immunodeficiency Virus Type 2: The Neglected Threat (Pathogens (Ceccarelli G et al.), via PubMed Central, 2021); Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds (International Journal of Molecular Sciences (Moranguinho I et al.), via PubMed Central, 2023); Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations (Centers for Disease Control and Prevention (CDC) and Association of Public Health Laboratories, 2014).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
